Search hospitals > Texas > Austin
Tekton Research, Inc
Claim this profileAustin, Texas 78745
Global Leader in Arthritis
Global Leader in Systemic Lupus Erythematosus
Conducts research for Osteoarthritis
Conducts research for Rheumatoid Arthritis
Conducts research for Migraine
111 reported clinical trials
3 medical researchers
Summary
Tekton Research, Inc is a medical facility located in Austin, Texas. This center is recognized for care of Arthritis, Systemic Lupus Erythematosus, Osteoarthritis, Rheumatoid Arthritis, Migraine and other specialties. Tekton Research, Inc is involved with conducting 111 clinical trials across 78 conditions. There are 3 research doctors associated with this hospital, such as Paul Pickrell, Daniel Peterson, MD, and Paul Keith Pickrell.Area of expertise
1Arthritis
Global Leader2Systemic Lupus Erythematosus
Global LeaderANA positive
dsDNA positive
anti-Smith positive
Top PIs
Paul PickrellTekton Research2 years of reported clinical research
Studies Arthritis
Studies Rheumatoid Arthritis
17 reported clinical trials
29 drugs studied
Daniel Peterson, MDAustin Neurosurgeons6 years of reported clinical research
Studies Degenerative Disc Disease
Studies Lumbar Spine Disease
5 reported clinical trials
7 drugs studied
Paul Keith PickrellTekton Research, Inc1 year of reported clinical research
Studies Lupus
Studies Systemic Lupus Erythematosus
2 reported clinical trials
3 drugs studied
Clinical Trials running at Tekton Research, Inc
Rheumatoid Arthritis
Arthritis
Ankylosing Spondylitis
Coronavirus
Psoriatic Arthritis
Osteoarthritis
Systemic Lupus Erythematosus
Lupus
Splenic Stimulation
for Rheumatoid Arthritis
This study will evaluate the safety, tolerability, and effects of stimulating the splenic neurovascular bundle (NVB) with the Galvani System, which consists of a lead, implantable pulse generator, external components and accessories. The study will consist of 4 study periods, including a Randomized Control Trial period (Period 1), an Open Label period (Period 2), a Treat-to-target period (Period 3), and a Long-term Follow-up period (Period 4). Participants eligible for implant will have active rheumatoid arthritis (RA) and have an inadequate response or intolerance to at least two biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) or JAK inhibitors (JAKis). A sufficient number of participants will be enrolled so that approximately 28 participants will undergo device implantation.
Recruiting2 awards N/A3 criteria
Upadacitinib vs Adalimumab
for Rheumatoid Arthritis
This trial is testing two medications, upadacitinib (a daily pill) and adalimumab (an injection), for adults with rheumatoid arthritis who haven't responded to other treatments. The study aims to see which drug is safer and more effective. Both medications work by reducing inflammation through different mechanisms in the immune system. Adalimumab, an injection, has been extensively studied and used for treating rheumatoid arthritis, showing significant improvements in patients who have not responded to other treatments.
Recruiting1 award Phase 35 criteria
Vagus Nerve Stimulation
for Rheumatoid Arthritis
The RESET-RA study will assess the safety and efficacy of the SetPoint System (study device) for the treatment of adult patients with active, moderate to severe rheumatoid arthritis who have had an inadequate response or intolerance to biologic or targeted synthetic Disease-Modifying Anti-Rheumatic Drugs (DMARDs). The study device contains a miniaturized stimulator (implant) that is surgically placed under general anesthesia on the vagus nerve through a small incision on the left side of the neck (implant procedure). The study will enroll 250 subjects at 40 sites. All eligible subjects will undergo the implant procedure. Half of the subjects will receive active stimulation (treatment) and the other half will receive non-active stimulation (control). After completing primary endpoint assessments at Week 12, there will be a one-way crossover of control subjects to active stimulation and a 180-week open-label follow-up with all subjects (treatment and control) receiving active stimulation to evaluate long-term safety.
Recruiting1 award Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Tekton Research, Inc?
Tekton Research, Inc is a medical facility located in Austin, Texas. This center is recognized for care of Arthritis, Systemic Lupus Erythematosus, Osteoarthritis, Rheumatoid Arthritis, Migraine and other specialties. Tekton Research, Inc is involved with conducting 111 clinical trials across 78 conditions. There are 3 research doctors associated with this hospital, such as Paul Pickrell, Daniel Peterson, MD, and Paul Keith Pickrell.